Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
about
Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis.Long-Term Ethanol Exposure Decreases the Endotoxin-Induced Hepatic Acute Phase Response in Rats.Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed ratsAcetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis.
P2860
Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Effect of resveratrol on exper ...... ology and timing of treatment.
@en
Effect of resveratrol on exper ...... ology and timing of treatment.
@nl
type
label
Effect of resveratrol on exper ...... ology and timing of treatment.
@en
Effect of resveratrol on exper ...... ology and timing of treatment.
@nl
prefLabel
Effect of resveratrol on exper ...... ology and timing of treatment.
@en
Effect of resveratrol on exper ...... ology and timing of treatment.
@nl
P2093
P2860
P50
P356
P1476
Effect of resveratrol on exper ...... hology and timing of treatment
@en
P2093
David Haldrup
Henning Grønbaek
Lars Porskjaer Christensen
Ylva Erika Kristina Hellberg
P2860
P304
P356
10.1111/JGH.13151
P577
2016-03-01T00:00:00Z